Skip to main content

Stream every public session from the 27th annual Global Conference right here on our website.

AmirAli Talasaz

< Back to previous page

AmirAli Talasaz

Co-Founder and Co-CEO, Guardant Health
AmirAli Talasaz

AmirAli Talasaz currently serves as co-founder and co-CEO of Guardant Health, a leading precision oncology company. AmirAli is an entrepreneur in the rare genomics and clinical diagnostics fields. Prior to co-founding Guardant Health, he was Senior Director of Diagnostics Research at Illumina and led the efforts for emerging clinical applications of next-generation genomic analysis. During that time, he developed different genomic technologies suitable for clinical applications. Before Illumina, he founded Auriphex Biosciences, which focused on purification and genetic analysis of circulating tumor cells for cancer management. The technology was acquired by Illumina in 2009. During his academic years, AmirAli led the Technology Development group at Stanford Genome Technology Center. AmirAli received his Ph.D. in electrical engineering and MSc in management science from Stanford University.